Kimberly Kraig Thompson Kraig Biocraft Laboratories, Inc (KBLB) insider trading activity

KBLB Quotes by TradingView

Kimberly Kraig Thompson is CEO & CFO of Kraig Biocraft Laboratories, Inc. Currently has a direct ownership of 202 Million shares of KBLB, which is worth approximately $16.1 Million. The most recent transaction as insider was on Jul 20, 2022, when has been sold 120,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202M
0% 3M change
0% 12M change
Total Value Held $16.1 Million

Kimberly Kraig Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2022
SELL
Open market or private sale
-
120,000 Reduced 0.06%
201,587,924 Common Stock
Jul 19 2022
SELL
Open market or private sale
-
50,000 Reduced 0.02%
201,707,924 Common Stock
Jul 18 2022
SELL
Open market or private sale
-
79,900 Reduced 0.04%
201,757,924 Common Stock
Jul 15 2022
SELL
Open market or private sale
-
50,000 Reduced 0.02%
201,837,824 Common Stock
Jul 13 2022
SELL
Open market or private sale
-
11,500 Reduced 0.01%
201,887,824 Common Stock
Jul 11 2022
SELL
Open market or private sale
-
100,000 Reduced 0.05%
201,899,324 Common Stock
Jul 08 2022
SELL
Open market or private sale
-
40,000 Reduced 0.02%
201,999,324 Common Stock
Jul 07 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,039,324 Common Stock
Jul 06 2022
SELL
Open market or private sale
-
60,000 Reduced 0.03%
202,059,324 Common Stock
Jul 05 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,119,324 Common Stock
Jun 29 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,139,324 Common Stock
Jun 28 2022
SELL
Open market or private sale
-
30,000 Reduced 0.01%
202,159,324 Common Stock
Jun 27 2022
SELL
Open market or private sale
-
50,000 Reduced 0.02%
202,189,324 Common Stock
Jun 24 2022
SELL
Open market or private sale
-
30,000 Reduced 0.01%
202,239,324 Common Stock
Jun 23 2022
SELL
Open market or private sale
-
80,000 Reduced 0.04%
202,269,324 Common Stock
Jun 22 2022
SELL
Open market or private sale
-
30,000 Reduced 0.01%
202,349,324 Common Stock
Jun 21 2022
SELL
Open market or private sale
-
180,000 Reduced 0.09%
202,379,324 Common Stock
Jun 17 2022
SELL
Open market or private sale
-
100,000 Reduced 0.05%
202,559,324 Common Stock
Jun 15 2022
SELL
Open market or private sale
-
10,000 Reduced 0.0%
202,659,324 Common Stock
Jun 08 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,669,324 Common Stock
Jun 06 2022
SELL
Open market or private sale
-
10,500 Reduced 0.01%
202,689,324 Common Stock
Jun 02 2022
SELL
Open market or private sale
-
10,000 Reduced 0.0%
202,699,824 Common Stock
Jun 01 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,709,824 Common Stock
May 27 2022
SELL
Open market or private sale
-
30,000 Reduced 0.01%
202,729,824 Common Stock
May 26 2022
SELL
Open market or private sale
-
10,000 Reduced 0.0%
202,759,824 Common Stock
KKT

Kimberly Kraig Thompson

CEO & CFO
Ann Arbor,, MI

Track Institutional and Insider Activities on KBLB

Follow Kraig Biocraft Laboratories, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KBLB shares.

Notify only if

Insider Trading

Get notified when an Kraig Biocraft Laboratories, Inc insider buys or sells KBLB shares.

Notify only if

News

Receive news related to Kraig Biocraft Laboratories, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KBLB